A responder analysis to demonstrate dupilumab treatment effect across objective and patient-reported endpoints for patients with severe chronic rhinosinusitis with nasal polyps (CRSwNP)

A responder analysis to demonstrate dupilumab treatment effect across objective and patient-reported endpoints for patients with severe chronic rhinosinusitis with nasal polyps (CRSwNP) Meeting Abstract

publication date

December 1, 2021

webpage

Web of Science

published in

CLINICAL AND EXPERIMENTAL ALLERGY Journal

start page

1665

end page

1666

volume

51

issue

12